Back to top

Ariad Pharmaceuticals (ARIA) Worth Watching: Stock Surges 19.7%
December 19, 2013

Read MoreHide Full Article

Ariad Pharmaceuticals Inc. (ARIA) was a big mover last session, as the company saw its shares jump nearly 20% on the day. This surge can be attributable to solid volume with far more shares changing hands than in a normal session. This continues the recent uptrend for the company, as the stock is now up almost 91% in the past one-month time frame.

In the last 30 days, this company did not witness any estimate revisions and the Zacks Consensus Estimate has remained unchanged. However, the recent price action is encouraging, so make sure to keep a close watch on this firm in the near future.

Ariad Pharmaceuticals currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.

However, some better performing stocks in the biopharmaceutical industry include Heska Corporation (HSKA - Free Report) , Actelion Ltd. and Jazz Pharmaceuticals plc (JAZZ - Free Report) , all with a Zacks Rank #1 (Strong Buy).

 Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>







In-Depth Zacks Research for the Tickers Above


Normally $25 each - click below to receive one report FREE:


Arena Pharmaceuticals, Inc. (ARNA) - free report >>

Heska Corporation (HSKA) - free report >>

Jazz Pharmaceuticals PLC (JAZZ) - free report >>


More from Zacks Tale of the Tape

You May Like